KOPP INVESTMENT ADVISORS LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
KOPP INVESTMENT ADVISORS LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,359,000
-46.9%
49,462
-36.1%
2.50%
-14.4%
Q2 2019$2,561,000
-26.9%
77,392
-22.6%
2.92%
+3.0%
Q1 2019$3,503,000
+38.8%
99,975
+31.6%
2.83%
+15.2%
Q4 2018$2,523,000
+20.1%
75,962
+82.2%
2.46%
+39.3%
Q3 2018$2,100,000
-16.2%
41,700
-0.4%
1.77%
-24.8%
Q2 2018$2,506,000
+47.9%
41,879
+13.3%
2.35%
+36.5%
Q1 2018$1,694,000
-3.6%
36,976
-16.2%
1.72%
-2.2%
Q4 2017$1,758,000
-4.1%
44,121
-3.7%
1.76%
+4.8%
Q3 2017$1,833,000
-7.1%
45,831
+0.1%
1.68%
-4.9%
Q2 2017$1,973,000
+35.4%
45,782
-1.7%
1.77%
+24.0%
Q1 2017$1,457,000
+25.5%
46,555
+1.2%
1.42%
+16.2%
Q4 2016$1,161,000
+0.3%
45,989
-1.8%
1.23%
+7.2%
Q3 2016$1,158,000
+18.8%
46,839
-2.2%
1.14%
+120.4%
Q2 2016$975,000
-90.5%
47,884
-93.4%
0.52%
-90.6%
Q3 2015$10,241,000
-32.3%
729,960
-18.0%
5.51%
-18.2%
Q2 2015$15,124,000
+103.9%
890,705
+45.2%
6.74%
+105.2%
Q1 2015$7,418,000
+47.7%
613,590
+1.4%
3.28%
+35.9%
Q4 2014$5,024,000
-19.8%
605,245
-16.1%
2.42%
-22.1%
Q3 2014$6,266,000
-13.9%
721,065
+8.5%
3.10%
-7.3%
Q2 2014$7,276,000
+390.6%
664,470
+300.7%
3.34%
+437.5%
Q1 2014$1,483,000165,8300.62%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders